Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

NSCLC patients who stopped immunotherapy due to side effects still showed lasting disease control and survival benefits..

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...

Most patients who enroll in the Lung-MAP precision medicine trial in non-small cell lung cancer can now be matched to a targeted investigational treatment based on the results of their prior genomic ...

How are advanced diagnostics benefitting patients? Our recent webinar discussed next-gen molecular analysis in precision ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small ...

Abu Dhabi is bringing the future of cancer care to the region with a world-class ‘heavy ion therapy’ facility in the UAE. It ...

An experimental drug now in clinical trials as a cancer treatment could help ... and less onerous therapies that reduce lung ...

In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...